Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity - PubMed (original) (raw)
Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity
I Bursuker et al. J Exp Med. 1984.
Abstract
This study shows that surgical removal of the meth A fibrosarcoma from its semisyngeneic host fails to result in postexcision immunity to growth of a tumor implant unless the host already has acquired a mechanism of concomitant immunity to growth of an implant. Therefore, tumor excision does not cause immunity to be generated but preserves a mechanism of concomitant immunity that already exists and which otherwise would eventually undergo down-regulation under the influence of suppressor T cells. Removal of the tumor after it has grown large enough to cause the T cell-mediated suppression of concomitant immunity does not result in the reemergence of immunity. Instead, the host remains unable to generate concomitant immunity to a second tumor for a long period of time and retains, for at least 31 d, suppressor T cells able to passively transfer suppression to appropriate recipients. Like the suppressor T cells responsible for active suppression of concomitant immunity, the suppressor T cells responsible for "memory" suppression are of the Ly-1+2- phenotype. The results indicate that progressive tumor growth results in a state of immunological tolerance of tumor-specific, transplantation antigens that can persist in the apparent absence of tumor antigens.
Similar articles
Cited by
- Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy.
Crittenden MR, Cottam B, Savage T, Nguyen C, Newell P, Gough MJ. Crittenden MR, et al. PLoS One. 2012;7(6):e39295. doi: 10.1371/journal.pone.0039295. Epub 2012 Jun 28. PLoS One. 2012. PMID: 22761754 Free PMC article. - Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor.
Zhang P, Côté AL, de Vries VC, Usherwood EJ, Turk MJ. Zhang P, et al. Cancer Res. 2007 Jul 1;67(13):6468-76. doi: 10.1158/0008-5472.CAN-07-1264. Cancer Res. 2007. PMID: 17616708 Free PMC article. - A positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.
Predina JD, Judy B, Fridlender ZG, Aliperti LA, Madajewski B, Kapoor V, Cheng G, Quatromoni J, Okusanya O, Singhal S. Predina JD, et al. Cancer Biol Ther. 2012 Jul;13(9):745-55. doi: 10.4161/cbt.20557. Epub 2012 May 23. Cancer Biol Ther. 2012. PMID: 22617772 Free PMC article. - Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
Ebina T, Kohya H, Ishikawa K. Ebina T, et al. Jpn J Cancer Res. 1989 Feb;80(2):158-66. doi: 10.1111/j.1349-7006.1989.tb02284.x. Jpn J Cancer Res. 1989. PMID: 2498250 Free PMC article.
References
- J Exp Med. 1981 Oct 1;154(4):1033-42 - PubMed
- Adv Cancer Res. 1983;39:71-120 - PubMed
- Cancer Res. 1964 Dec;24:1994-6 - PubMed
- Annu Rev Med. 1964;15:167-86 - PubMed
- Immunol Rev. 1979;46:3-26 - PubMed